Condition: Mixed Urinary Incontinence · Stress Urinary Incontinence (SUI) · Chronic Pelvic Pain · Sponsor: Amber Therapeutics Ltd
Exploratory safety and feasibility study of personalized adaptive pudendal neuromodulation for mixed urinary incontinence and extended indications using an implanted (Picostim™ II) system.
This description comes directly from the study's public registry record.
Amber Clinical Affairs · 08000418515 · AURA-4X@amber-tx.com
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Herestraat 49, Belgium | Recruiting |
| Universitair Ziekenhuis Antwerpen | Edegem, Belgium | Recruiting |
| Ghent University Hospital | Ghent, Belgium | Recruiting |
| Maastricht UMC | Maastricht, Netherlands | Recruiting |
| Southmead Hospital | Bristol, United Kingdom | Recruiting |
| University College London Hospital | London, United Kingdom | Recruiting |
| Guy's Hospital | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06885931